GBIO
Price
$0.36
Change
-$0.01 (-2.70%)
Updated
Jun 25 closing price
Capitalization
24.45M
41 days until earnings call
GLSI
Price
$9.00
Change
-$0.05 (-0.55%)
Updated
Jun 25 closing price
Capitalization
120.31M
46 days until earnings call
Interact to see
Advertisement

GBIO vs GLSI

Header iconGBIO vs GLSI Comparison
Open Charts GBIO vs GLSIBanner chart's image
Generation Bio
Price$0.36
Change-$0.01 (-2.70%)
Volume$601.73K
Capitalization24.45M
Greenwich LifeSciences
Price$9.00
Change-$0.05 (-0.55%)
Volume$29.12K
Capitalization120.31M
GBIO vs GLSI Comparison Chart in %
Loading...
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GBIO vs. GLSI commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GBIO is a Buy and GLSI is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (GBIO: $0.36 vs. GLSI: $9.00)
Brand notoriety: GBIO and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GBIO: 114% vs. GLSI: 64%
Market capitalization -- GBIO: $24.45M vs. GLSI: $120.31M
GBIO [@Biotechnology] is valued at $24.45M. GLSI’s [@Biotechnology] market capitalization is $120.31M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GBIO’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • GBIO’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, GBIO is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GBIO’s TA Score shows that 3 TA indicator(s) are bullish while GLSI’s TA Score has 3 bullish TA indicator(s).

  • GBIO’s TA Score: 3 bullish, 6 bearish.
  • GLSI’s TA Score: 3 bullish, 7 bearish.
According to our system of comparison, GBIO is a better buy in the short-term than GLSI.

Price Growth

GBIO (@Biotechnology) experienced а +1.31% price change this week, while GLSI (@Biotechnology) price change was +0.90% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

GBIO is expected to report earnings on Aug 06, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($120M) has a higher market cap than GBIO($24.4M). GLSI YTD gains are higher at: -19.858 vs. GBIO (-65.594). GLSI has higher annual earnings (EBITDA): -16.75M vs. GBIO (-69.2M). GBIO has more cash in the bank: 158M vs. GLSI (2.75M). GBIO has higher revenues than GLSI: GBIO (24.6M) vs GLSI (0).
GBIOGLSIGBIO / GLSI
Capitalization24.4M120M20%
EBITDA-69.2M-16.75M413%
Gain YTD-65.594-19.858330%
P/E RatioN/AN/A-
Revenue24.6M0-
Total Cash158M2.75M5,745%
Total Debt87.6MN/A-
TECHNICAL ANALYSIS
Technical Analysis
GBIOGLSI
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 24 days ago
85%
Bullish Trend 21 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
GBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCAB0.410.01
+2.81%
BioAtla
HUT17.450.21
+1.22%
Hut 8 Corp
BIIB127.311.00
+0.79%
Biogen
HWC55.91-0.23
-0.41%
Hancock Whitney Corp
TTEC4.80-0.08
-1.64%
TTEC Holdings

GBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, GBIO has been loosely correlated with CCCC. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if GBIO jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GBIO
1D Price
Change %
GBIO100%
-1.51%
CCCC - GBIO
50%
Loosely correlated
-1.28%
ATXS - GBIO
49%
Loosely correlated
-1.91%
IDYA - GBIO
48%
Loosely correlated
+1.06%
FHTX - GBIO
48%
Loosely correlated
+0.62%
IPSC - GBIO
47%
Loosely correlated
-4.74%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
-0.55%
ABOS - GLSI
45%
Loosely correlated
-2.38%
DNLI - GLSI
43%
Loosely correlated
+0.35%
XBIT - GLSI
42%
Loosely correlated
-0.37%
CLDX - GLSI
42%
Loosely correlated
-0.88%
BEAM - GLSI
41%
Loosely correlated
-2.27%
More